Experience with mesocaval shunt with autologous jugular vein interposition in patients with Budd-Chiari syndrome

Basit Öğe Kaydı
dc.contributor.authorIlkgul, O
dc.contributor.authorKilic, M
dc.contributor.authorIcoz, G
dc.contributor.authorZeytunlu, M
dc.contributor.authorDemirpolat, G
dc.contributor.authorAkyildiz, M
dc.contributor.authorTokat, Y
dc.contributor.authorParildar, M
dc.contributor.authorMemis, A
dc.date.accessioned2019-10-27T18:58:14Z
dc.date.available2019-10-27T18:58:14Z
dc.date.issued2005
dc.departmentEge Üniversitesien_US
dc.description.abstractBackground/Aims: In the present era of interventional. radiology and liver transplantation, the role of mesocaval shunt surgery for portal hypertension in Budd-Chiari syndrome is reviewed. Methodology: This study analyzed the management of 35 patients with Budd-Chiari syndrome between June 1994 and June 2004 in our institution. During this 10-year interval, 31 of the 35 patients with Budd-Chiari syndrome underwent shunt procedures and four patients underwent liver transplantation. Mesocaval shunts were preferred in 27 patients and seven of these patients required prior caval stenting. One portocaval shunt was performed in a patient having a thrombosed mesocaval shunt. In all mesocaval. shunt procedures the patient's internal jugular vein was used as an interposition graft between the superior mesenteric vein and inferior vena cava. In four patients with thrombosed vena cava a mesoatrial shunt was performed using poly-tetrafluoroethylene graft while four patients with established cirrhosis under-went orthotopic liver transplantation. Results: In the group of mesocaval shunts, 3 patients were lost in the early postoperative period with a mortality rate of 11%, 2 of them due to thrombosed shunts and one of them due to pneumonia. The median follow-up was 42 months (6-120 months) and one patient experienced shunt thrombosis and died afterwards due to the complications of portal hypertension. In the whole series the patency rate of the mesocaval shunt was 89%. Conclusions: Patients with Budd-Chiari syndrome can be managed by a combination of shunt surgery, interventional radiology and liver transplantation. Our results demonstrate the effectiveness of mesocaval shunt procedure with autologous jugular vein interposition to maintain long-term patency and survival.en_US
dc.identifier.endpage665en_US
dc.identifier.issn0172-6390
dc.identifier.issue63en_US
dc.identifier.pmid15966177en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage662en_US
dc.identifier.urihttps://hdl.handle.net/11454/37436
dc.identifier.volume52en_US
dc.identifier.wosWOS:000229759000003en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherH G E Update Medical Publishing S Aen_US
dc.relation.ispartofHepato-Gastroenterologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectBudd-Chiarien_US
dc.subjectmesocaval shunten_US
dc.subjectjugular veinen_US
dc.titleExperience with mesocaval shunt with autologous jugular vein interposition in patients with Budd-Chiari syndromeen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu